{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T04:41:49Z","timestamp":1780375309529,"version":"3.54.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773265"],"award-info":[{"award-number":["81773265"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004303","name":"Shaanxi Normal University","doi-asserted-by":"publisher","award":["1110020197"],"award-info":[{"award-number":["1110020197"]}],"id":[{"id":"10.13039\/501100004303","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013317","name":"Shanxi Provincial Key Research and Development Project","doi-asserted-by":"publisher","award":["2023-JC-YB-642"],"award-info":[{"award-number":["2023-JC-YB-642"]}],"id":[{"id":"10.13039\/501100013317","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007128","name":"Shaanxi Province Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007128","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.bcp.2024.116412","type":"journal-article","created":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T01:21:15Z","timestamp":1720142475000},"page":"116412","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["BI-7273, a BRD9 inhibitor, reduces lipid accumulation by downregulating the AKT\/mTOR\/SREBP1 signaling pathway"],"prefix":"10.1016","volume":"226","author":[{"given":"Yu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiongyan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huma","family":"Dli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junli","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinwen","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2038-5759","authenticated-orcid":false,"given":"Haibin","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.bcp.2024.116412_b0005","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease[J]","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bcp.2024.116412_b0010","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jhep.2019.03.004","article-title":"Global liver disease burdens and research trends: analysis from a Chinese perspective","volume":"71","author":"Xiao","year":"2019","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.bcp.2024.116412_b0015","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","article-title":"Non-alcoholic fatty liver disease\u2013a global public health perspective [J]","volume":"70","author":"Younossi","year":"2019","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.bcp.2024.116412_b0020","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S2468-1253(19)30039-1","article-title":"Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999\u20132019: a systematic review and meta-analysis [J]","volume":"4","author":"Li","year":"2019","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.bcp.2024.116412_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-017-0806-8","article-title":"Non-alcoholic fatty liver disease [J]","volume":"15","author":"Neuschwander-Tetri","year":"2017","journal-title":"BMC Med."},{"issue":"11","key":"10.1016\/j.bcp.2024.116412_b0030","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.biochi.2004.09.018","article-title":"SREBP transcription factors: master regulators of lipid homeostasis [J]","volume":"86","author":"Eberle","year":"2004","journal-title":"Biochimie"},{"issue":"2","key":"10.1016\/j.bcp.2024.116412_b0035","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.tem.2011.10.004","article-title":"SREBPs: metabolic integrators in physiology and metabolism [J]","volume":"23","author":"Jeon","year":"2012","journal-title":"Trends Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.bcp.2024.116412_b0040","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1139\/o03-090","article-title":"Molecular regulation of SREBP function: the Insig-SCAP connection and isoform-specific modulation of lipid synthesis [J]","volume":"82","author":"McPherson","year":"2004","journal-title":"Biochem. Cell Biol."},{"issue":"12","key":"10.1016\/j.bcp.2024.116412_b0045","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nrendo.2017.91","article-title":"SREBP-regulated lipid metabolism: convergent physiology\u2014divergent pathophysiology [J]","volume":"13","author":"Shimano","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"issue":"3","key":"10.1016\/j.bcp.2024.116412_b0050","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.cmet.2008.07.007","article-title":"SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth [J]","volume":"8","author":"Porstmann","year":"2008","journal-title":"Cell Metab."},{"issue":"6","key":"10.1016\/j.bcp.2024.116412_b0055","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.cmet.2016.04.022","article-title":"Direct hepatocyte insulin signaling is required for lipogenesis but is dispensable for the suppression of glucose production","volume":"23","author":"Titchenell","year":"2016","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.bcp.2024.116412_b0060","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.cmet.2011.01.008","article-title":"Brain insulin controls adipose tissue lipolysis and lipogenesis","volume":"13","author":"Scherer","year":"2011","journal-title":"Cell Metab."},{"issue":"11","key":"10.1016\/j.bcp.2024.116412_b0065","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.7150\/ijbs.27173","article-title":"The PI3K\/AKT pathway in obesity and type 2 diabetes","volume":"14","author":"Huang","year":"2018","journal-title":"Int J Biol Sci."},{"issue":"5","key":"10.1016\/j.bcp.2024.116412_b0070","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1038\/sj.jid.5701155","article-title":"IGF-1 induces SREBP-1 expression and lipogenesis in SEB-1 sebocytes via activation of the phosphoinositide 3-kinase\/Akt pathway","volume":"128","author":"Smith","year":"2008","journal-title":"J Invest Dermatol."},{"key":"10.1016\/j.bcp.2024.116412_b0075","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.bbrc.2022.03.012","article-title":"Bacillus natto ameliorates obesity by regulating PI3K\/AKT pathways in rats","volume":"603","author":"Sun","year":"2022","journal-title":"Biochem Biophys Res Commun."},{"issue":"12","key":"10.1016\/j.bcp.2024.116412_b0080","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3390\/toxins14120833","article-title":"MC-LR aggravates liver lipid metabolism disorders in obese mice fed a high-fat diet via PI3K\/AKT\/mTOR\/SREBP1 signaling pathway","volume":"14","author":"Chu","year":"2022","journal-title":"Toxins (basel)."},{"issue":"12","key":"10.1016\/j.bcp.2024.116412_b0085","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.tig.2020.07.011","article-title":"Mammalian SWI\/SNF chromatin remodeling complexes: emerging mechanisms and therapeutic strategies","volume":"36","author":"Centore","year":"2020","journal-title":"Trends Genet."},{"issue":"4","key":"10.1016\/j.bcp.2024.116412_b0090","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1158\/0008-5472.CAN-20-1417","article-title":"BRD9 Is a Critical Regulator of Androgen Receptor Signaling and Prostate Cancer Progression","volume":"81","author":"Alpsoy","year":"2021","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.bcp.2024.116412_b0095","doi-asserted-by":"crossref","first-page":"995","DOI":"10.3390\/ijms24020995","article-title":"Bromodomain (BrD) family members as regulators of cancer stemness-a comprehensive review","volume":"24","author":"Czerwinska","year":"2023","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.bcp.2024.116412_b0100","doi-asserted-by":"crossref","first-page":"13191","DOI":"10.2147\/OTT.S286867","article-title":"Targeting BRD9 for cancer treatment: a new strategy","volume":"13","author":"Zhu","year":"2020","journal-title":"Onco Targets Ther."},{"issue":"5","key":"10.1016\/j.bcp.2024.116412_b0105","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.cell.2018.04.013","article-title":"Vitamin D switches BAF complexes to protect \u03b2 cells","volume":"173","author":"Wei","year":"2018","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.bcp.2024.116412_b0110","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/s41366-020-0564-0","article-title":"Calcipotriol and iBRD9 reduce obesity in Nur77 knockout mice by regulating the gut microbiota, improving intestinal mucosal barrier function","volume":"44","author":"Lv","year":"2020","journal-title":"Int J Obes (lond)."},{"issue":"11\u201312","key":"10.1016\/j.bcp.2024.116412_b0115","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s10529-018-2608-2","article-title":"Establishment of a HEK293 cell line by CRISPR\/Cas9-mediated luciferase knock-in to study transcriptional regulation of the human SREBP1 gene","volume":"40","author":"Li","year":"2018","journal-title":"Biotechnol Lett."},{"issue":"12","key":"10.1016\/j.bcp.2024.116412_b0120","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1002\/oby.23572","article-title":"Rutaecarpin 7reduces lipids by DGK\u03b8-dependent activation of PPAR\u03b1","volume":"30","author":"Wu","year":"2022","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.bcp.2024.116412_b0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-031-00793-4_1","article-title":"Fatty acid synthase: structure, function, and regulation","volume":"99","author":"G\u00fcnenc","year":"2022","journal-title":"Subcell Biochem."},{"key":"10.1016\/j.bcp.2024.116412_b0130","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.bbrc.2022.08.092","article-title":"The role of Stearoyl-CoA desaturase in hepatic de novo lipogenesis","volume":"633","author":"Ntambi","year":"2022","journal-title":"Biochem Biophys Res Commun."},{"issue":"4","key":"10.1016\/j.bcp.2024.116412_b0135","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.cmet.2011.09.001","article-title":"Postprandial hepatic lipid metabolism requires signaling through Akt2 independent of the transcription factors FoxA2, FoxO1, and SREBP1c","volume":"14","author":"Wan","year":"2011","journal-title":"Cell Metab."},{"key":"10.1016\/j.bcp.2024.116412_b0140","doi-asserted-by":"crossref","unstructured":"Yecies JL, Zhang HH, Menon S, et al. Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways [published correction appears in Cell Metab. 2011 Aug 3;14(2):280]. Cell Metab. 2011;14(1):21-32.","DOI":"10.1016\/j.cmet.2011.06.002"},{"issue":"5","key":"10.1016\/j.bcp.2024.116412_b0145","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3390\/molecules21050586","article-title":"Soy isoflavones regulate lipid metabolism through an AKT\/mTORC1 pathway in diet-induced obesity (DIO) male rats","volume":"21","author":"Huang","year":"2016","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.bcp.2024.116412_b0150","doi-asserted-by":"crossref","first-page":"G387","DOI":"10.1152\/ajpgi.00350.2018","article-title":"AKT activator SC79 protects hepatocytes from TNF-\u03b1-mediated apoptosis and alleviates d-Gal\/LPS-induced liver injury","volume":"316","author":"Jing","year":"2019","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"issue":"2","key":"10.1016\/j.bcp.2024.116412_b0155","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41575-020-00406-0","article-title":"Nonalcoholic fatty liver disease: another leap forward","volume":"18","author":"Abdelmalek","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol."},{"issue":"1","key":"10.1016\/j.bcp.2024.116412_b0160","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/imr.12891","article-title":"Lipids, inflammasomes, metabolism, and disease","volume":"297","author":"Anand","year":"2020","journal-title":"Immunol Rev."},{"issue":"5","key":"10.1016\/j.bcp.2024.116412_b0165","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.bbadis.2018.06.023","article-title":"Animal models of NAFLD from a hepatologist's point of view","volume":"1865","author":"Jahn","year":"2019","journal-title":"Biochim Biophys Acta Mol Basis Dis."},{"issue":"12","key":"10.1016\/j.bcp.2024.116412_b0170","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.3748\/wjg.v25.i12.1492","article-title":"Ursodeoxycholic acid ameliorates hepatic lipid metabolism in LO2 cells by regulating the AKT\/mTOR\/SREBP-1 signaling pathway","volume":"25","author":"Hu","year":"2019","journal-title":"World J Gastroenterol."},{"issue":"11","key":"10.1016\/j.bcp.2024.116412_b0175","doi-asserted-by":"crossref","first-page":"e13034","DOI":"10.1111\/jfbc.13034","article-title":"Kaempferol reduces hepatic triglyceride accumulation by inhibiting Akt","volume":"43","author":"Hoang","year":"2019","journal-title":"J Food Biochem."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224003952?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224003952?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T00:12:30Z","timestamp":1728346350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295224003952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":35,"alternative-id":["S0006295224003952"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116412","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BI-7273, a BRD9 inhibitor, reduces lipid accumulation by downregulating the AKT\/mTOR\/SREBP1 signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116412","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116412"}}